biogen and other ones these are monster performers for the year. that's leading the ivb the index that tracks bioteches. that's up 53%. whenever you see the markets fluctuate up or down, biogen and bioteches tend to exaggerate those moves. more sharply up or more sharply down. that is a danger with these. apple, can't forget about that one. earnings after the bell on monday. >> i mean with apple you can talk about the headline earnings and sales numbers all you want but this is a company that traditionally beats earnings and sales. last few quarters a little iffy. forget about that, beyond those headlines typically companies like to announce things like dividend policy or buyback policy in conjunction with these particular announcements so a lot of investors waiting to see whether carl icahn has influenced maybe a little bit about how they're going to conduct their dividend policy or buybacks going forward. >> i'll be waiting to see if tim cook calls carl icahn like he said he would after the earnings come out. >> that's going to be a huge one for

he's accused of purchasing peds, trying to get other players to go to biogen sis.pting to tamper with the investigation. that's on one side. then you got selig on the other who presided over this whole era of steroids. turned the other cheek. let barry bonds and all those guys juice up and hit home runs in the home run derby just to get the eyes back on baseball and now he's supposed to clean it up? >> he's done a very good job cleaning it up. jose can sayco deserves a lot of credit. and that brought the union to table. and now that bud selig could actually do his job. bob, i want you to weigh in, he says that a-rod's suing because major league baseball paid for this guy who owns biogen sis to be a witness. >> i hope they did. i mean, it seeps to be biogenesis has been around a lot of this scandal. maybe 5%, 8%. if you have to get this stuff and you can't get it any other way, if you got to buy it, buy it. >> exactly. dana, what about integrity? even if he ends up winning the lawsuit? we all know he cheated. >> i do think there are just way too many lawyers. >> in

. >>> sales of biogen, the ms drug, topping analyst estimates, giving that drug a boost. they reported better than expected earnings and raised its four-year estimates. shares rose a fraction to $254.43. >>> and edward life sciences reporting earnings, investors were disappointed with the u.s. sales of the nonsurgical artificial heart valve and the week guidance. the stock plunged to 73.24. shares of cf industries climbing after mosaic announce they would buy the companies phosphate business, the deal sent the shares up to 1386. mosaic up about one and a half percent. >>> and liberty global selling its international content division to amc for about a billion. they will help to expand the outreach and distribute popular shows like "breaking bad" overseas, shares slipped to 1690. liberty global was up to 81112. >> are you happy with your job? if not, things may get better as you get older. a new study byñr the associated press and the center for public affairs research finds that nine out of ten workers age 50 and older say they're either very or somewhat satisfied with th

. >>> biogen is releasing a study from multiple sclorsis. it closed at $240.30 per share. >>> union pacific is forecasting profits coming in below expectations. the rail road operator is blaming the economy and the cole that needed to be shipped. it fell to $153.90. >>> the political crisis in washington is quote, man made and investors should look beyond that and invest for the long term. he's chief investment officer at bmo private bank. nice to see you. >> thank you, suzy. >>> what if things get dicey on wall street and we see sell offs, are you telling invest tors to sit tight? >> yeah, it's really sort of a decision if you believe that the government will ultimately default on obligations you probably don't want to own anything including risk assets, but on the other hand if you think they will ultimately kind of work their way through this, and there is somehow light at the end of this tunnel, then probably holding risk assets like equities probably make sense through here. >> jack, reaching for yield these days has been a dicey prospe

they've continually come out with good news, gill add on friday, biogen, where you can make money. if you look out just one year, two years, you are going to see stocks, selling at a discount to the market multiples. i think you've got huge, huge growth. you can go there. what you'll see temper continually are autos but the -- >> maybe bristol-myerss a name though it's not a traditional biotech, it's morphed into that you can play that like it's being played today on positive date it. we like bmy? >> the story always there is, is it an exit story? are they going to sell? it's run by a good management team, done extremely well. i think you get a bigger bang. >> the answer, where the money's going to be made? i could make the case a meltup in emerging markets, they're down 6% year-to-date versus every other geography which is up substantially. that's an area where hedge funds can taye, this doesn't feel criminal buying markets at china, 10, 11 times earnings, india, 10, 11 times earnings. that could be the next area where the puck is going. >> josh, by the way, real quick, one of the

and given we've been at this 2,000 times, you know we mean it when i say they're not celgene or biogenthe sons and daughters of the four horse men of the big pharma apocalypse. stick with cramer. iona. tell me fiona, who's having a big tire event? your ford dealer. who has 11 major brands to choose from? your ford dealer. who's offering a rebate? your ford dealer. who has the low price tire guarantee, affording peace of mind to anyone who might be in the market for a new set of tires? your ford dealer. i'm beginning to sense a pattern. get up to $140 in mail-in rebates when you buy four select tires with the ford service credit card. where'd you get that sweater vest? your ford dealer. at bny mellon, our business is investments. managing them, moving them, making them work. we oversee 20% of the world's financial assets. and that gives us scale and insight no one else has. investment management combined with investment servicing. bringing the power of investments to people's lives. invested in the world. bny mellon. humans. we are beautifully imperfect creatures living in an imperfect

red at the last couple of days, but it's not enough to finish in the green for names like vertex, biogenn to you. >> thank you, courtney. >> we got this new market data software on our computer today. >> we love it. >> we're feeling pretty good about it. what's the best performing international market this week? >> argentina. >> very good. >> how much is it up in the last year? 116%. >> wow. how about mexico, my favorite? >> mexico is down this week. down 1.6%. >> what about year to date, bill? >> down 1.9%. >> year to date? wow. okay, okay. >> go ahead, ask us anything. we've got it now. >> you know what i want to do next? i want to get some earnings expectations and pe ratios. >> we can do that. >> market cap and percent changes. >> we can do that. >> six months, a year. we are swimming in data. >> the dow's up 72 points. we can tell you that with 14 minutes left. >> are we setting ours up for a major selloff if things fall apart this weekend? we'll look at scenarios next. [ female announcer ] it's time for the annual shareholders meeting. ♪ there'll be the usual presentations on resea

and biogen also raising the full-year outlook.by 3 cents, third quarter profit of $1.32 a share. revenue also fell short. cut the full-year forecast saying growth in some of the markets will be slower than expected during the current quarter. and andrew met john ritter on the set of -- >> years ago. >> three's company. >> do you remember who follows -- who followed mr. roper? there was a lot of changes. do you remember? i finally came up with it. >> who? >> don knots. >> loved him. >> yeah. >> i thought about wearing an ascot back then. >> oh, my god. oh, my god. >> what? >> i had a bow tie. >> that's priceless. you've got to invite me back for that date. >> i don't know how to tie a bow tie and i don't know how to work excel. >>> and crocs is taking a hit this morning. >> i'm not allowed to go outside with them. >> your wife has a lot of rules. >> there are a lot of rules. >> there's a lot of rules. >> no cargo shorts. >> no crocs. >> no sex during the week. >> where did you -- that -- i didn't know about that rule. >> tmi. >> do

. >> biogen is going to open at a record high. >> biogen, not afraid to cannibalize other m.s. drugs. they brought in the rights. i look at merck and i see the animal health business, which has been so great, not doing well, versus pfizer when they spin off. merck is under fire here. merck has no game. >> no game? >> no game in this great-american one. >> speaking of companies trying to find their game, it is going to be apple due to issue and results after the bell. waiting to see what the tech giant will say of sales of the new iphone 5-s and the 5-c. the call is on to see the response to carl icahn's buy back program. >> they did kind of give you awe higher estimate. they sold 9 million over that weekend. they gave you the high-end. i have to think apple is very cheap. very cheap doesn't necessarily get things going. the two things that disturb me about apple, the bar is raised by the fact that they raised the bar on the high end for the apple file that they mate september 23rd. icah flchlt has made it to feel like there is not a lot of down side. they are going to have to g

president obama -- and i was reading this in ben white's newsletter this morning -- that president obama biogene sperling suggested that perhaps they could reach some kind of very short-term deal just for a couple weeks. if the president were to extend that, then what had what happens? the question then becomes -- are you held hostage all over again? >> but what if the president did say, you know what? there is some merit to the idea that we do a lot bit here with -- i want the sequester, i don't like it. let's work on that a little. i agree that long-term entitlements, we should take one step or develop a plan to get a plan for that. let's talk about that. so we'll delay this for three weeks or six weeks. let's get this -- our ducks in a row on how we're going to approach that. >> the president wouldn't say that unless it's. >> would anybody be in the. >> the guy if he doesn't play ball and it does happen, that the first time it happened in u.s. -- well, it did happen one or time. but it would be president obama. >> they might think that it -- and also if it doesn't work out well, the rest of h

we have positive comments on celgene, positive on biogen, positive comments on vivis.of things that keep driving the nasdaq. yahoo! alibaba. >> cardinal health celebrating the president's cup in dublin, ohio with world golf hall of famer jack nicklaus. at nasdaq, susan g coleman foundation recognizing breast cancer awareness month. have you already touched on the notion that ackman has restructured 40% of his short? >> i think that's a prudent way to approach. if you think there's going to be a squeeze, you do a put. what am i going to say? right thing to do to limit your ri risk. >> it's a wonder he hadn't done it sooner. a very difficult position to risk adjust is what many people will tell you, having taken up as much as 12% or more of his funds under management. you have to imagine it was a concern for him after the jcpenney debacle, down 50% or more and his installation of ron johnson as ceo, which hurt so many people and herbalife. but he did have a win on air products. we'll see how the stock actually does over i'm. but interesting moves on his part. interesting